PMID- 22611747
OWN - NLM
STAT- MEDLINE
DCOM- 20120628
LR  - 20131121
IS  - 0011-4162 (Print)
IS  - 0011-4162 (Linking)
VI  - 89
IP  - 4
DP  - 2012 Apr
TI  - Subacute cutaneous lupus erythematosus: a case report of Polypodium leucotomos as 
      an adjuvant therapy.
PG  - 183-4
AB  - Subacute cutaneous lupus erythematosus (SCLE) is an uncommon autoimmune disease 
      that results in substantial photosensitivity of affected patients. Eruptions 
      often are triggered or exacerbated by UV light (UVL) exposure. We present a case 
      of a patient with SCLE who was moderately controlled with hydroxychloroquine 
      sulfate but achieved near total remission of disease after the addition of oral 
      Polypodium leucotomos supplement which has photoprotective effects on human 
      keratinocytes. We report sustained clinical response with the use of P leucotomos 
      in lupus and suggest that it may have future application in photosensitizing 
      dermatoses.
FAU - Breithaupt, Andrew D
AU  - Breithaupt AD
AD  - Department of Dermatology and Cutaneous Surgery, University of California, San 
      Diego, Rady Children's Hospital, 92123, USA.
FAU - Jacob, Sharon E
AU  - Jacob SE
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Cutis
JT  - Cutis
JID - 0006440
RN  - 0 (Antioxidants)
RN  - 0 (Plant Extracts)
RN  - 4QWG6N8QKH (Hydroxychloroquine)
SB  - IM
MH  - Administration, Oral
MH  - Antioxidants/*administration & dosage
MH  - Chemotherapy, Adjuvant
MH  - Humans
MH  - Hydroxychloroquine/*administration & dosage
MH  - Lupus Erythematosus, Cutaneous/*diagnosis/*drug therapy
MH  - Male
MH  - Middle Aged
MH  - Plant Extracts/*administration & dosage
MH  - *Polypodium
MH  - Treatment Outcome
EDAT- 2012/05/23 06:00
MHDA- 2012/06/29 06:00
CRDT- 2012/05/23 06:00
PHST- 2012/05/23 06:00 [entrez]
PHST- 2012/05/23 06:00 [pubmed]
PHST- 2012/06/29 06:00 [medline]
PST - ppublish
SO  - Cutis. 2012 Apr;89(4):183-4.